Letter: disentangling the role of redox-active compounds in the development of inflammatory bowel diseases – moving towards causal associations

Sem Geertsema; Harry van Goor; Gerard Dijkstra; Klaas Nico Faber; Arno R. Bourgonje

doi:10.1111/apt.17455

Letter: disentangling the role of redox-active compounds in the development of inflammatory bowel diseases – moving towards causal associations

Sem Geertsema, Harry van Goor, Gerard Dijkstra, Klaas Nico Faber, Arno R. Bourgonje^*

^*Corresponding author voor dit werk

Onderzoeksoutput › Academic › peer review

1 Citaat (Scopus)

52 Downloads (Pure)

Originele taal-2	English
Pagina's (van-tot)	1046-1047
Aantal pagina's	2
Tijdschrift	Alimentary Pharmacology & Therapeutics
Volume	57
Nummer van het tijdschrift	9
Vroegere onlinedatum	13-apr.-2023
DOI's	https://doi.org/10.1111/apt.17455
Status	Published - mei-2023

Toegang tot document

10.1111/apt.17455

Letter: disentangling the role of redox-active compounds in the development of inflammatory bowel diseases – moving towards causal associationsFinal publisher's version, 221 KBLicentie: Taverne

Handle.net

Permanente koppeling

Citeer dit

@article{567d026de59648bb9d35cbfb058a2605,

title = "Letter: disentangling the role of redox-active compounds in the development of inflammatory bowel diseases – moving towards causal associations",

keywords = "Humans, Inflammatory Bowel Diseases/drug therapy, Oxidation-Reduction",

author = "Sem Geertsema and {van Goor}, Harry and Gerard Dijkstra and Faber, {Klaas Nico} and Bourgonje, {Arno R.}",

year = "2023",

month = may,

doi = "10.1111/apt.17455",

language = "English",

volume = "57",

pages = "1046--1047",

journal = "Alimentary Pharmacology & Therapeutics",

issn = "0269-2813",

publisher = "Wiley",

number = "9",

}

TY - JOUR

T1 - Letter: disentangling the role of redox-active compounds in the development of inflammatory bowel diseases – moving towards causal associations

AU - Geertsema, Sem

AU - van Goor, Harry

AU - Dijkstra, Gerard

AU - Faber, Klaas Nico

AU - Bourgonje, Arno R.

PY - 2023/5

Y1 - 2023/5

KW - Humans

KW - Inflammatory Bowel Diseases/drug therapy

KW - Oxidation-Reduction

U2 - 10.1111/apt.17455

DO - 10.1111/apt.17455

M3 - Comment/Letter to the editor

C2 - 37053479

SN - 0269-2813

VL - 57

SP - 1046

EP - 1047

JO - Alimentary Pharmacology & Therapeutics

JF - Alimentary Pharmacology & Therapeutics

IS - 9

ER -